부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Product news | Bukwang Medica launches “Probiotics”
Bukwang Medica, Bukwang Pharm’s subsidiary company, launched “Probiotics” in coo..
2016.06.27
Product news | Bukwang Pharmaceutical Co., Ltd. launched ‘BUKWANGTAX M’ ..
Bukwang Pharmaceutical Co., Ltd. recently launched ‘BUKWANGTAX M’ which is based..
2016.06.23
Product news | Bukwang Pharmaceutical Co., Ltd. eliminates parben from the..
Ministry of Food and Drug Safety recently announced amendment of ‘Sanitary Aid P..
2016.06.14
R&D news | Bukwang Pharmaceuticals Co., Ltd. announces positive Phase ..
Melior Pharmaceuticals I, Inc (Melior) and Bukwang Pharmaceuticals Co., Ltd. (Bu..
2016.06.13
Product news | Ixel Cap. confirmed as 1st line treatment of fibromyalgia
The Korean Pain Society held the first International Congress on Spinal Pain (IC..
2016.06.08
Company news | Bukwang Pharm. participates in APASL STC 2016, largest inte..
The GI (gastrointestinal) department of Bukwang Pharmaceutical Co., Ltd. partici..
2016.06.01
11
12
13
14
15